Citation Impact
Citing Papers
Pathogenicity Islands in BacterialPathogenesis
2004
DiarrheagenicEscherichia coli
1998 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Estimates of the Burden of Foodborne Illness in Canada for 30 Specified Pathogens and Unspecified Agents, Circa 2006
2013
A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection
2009
Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study
2008
A Norovirus Outbreak at a Long-Term-Care Facility: The Role of Environmental Surface Contamination
2005
De Novo Prediction of Three-dimensional Structures for Major Protein Families
2002 StandoutNobel
Enteric infections
1990
Effect of method of delivery of sodium butyrate on rumen development in newborn calves
2011 Standout
Short‐Chain Fatty Acids Improve Clinical, Pathologic, and Microbiologic Features of Experimental Shigellosis
1999
Prosthetic-Joint Infections
2004 Standout
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Molecular and Cellular Biology of Shigella flexneri Invasiveness: From Cell Assay Systems to Shigellosis
1992
Waterborne transmission of protozoan parasites: Review of worldwide outbreaks - An update 2011–2016
2017 Standout
Enteric Pathogens and Reactive Arthritis: A Systematic Review of Campylobacter, Salmonella and Shigella-associated Reactive Arthritis
2013
Crohn's disease
2012 Standout
High-resolution structure of the Shigella type-III secretion needle by solid-state NMR and cryo-electron microscopy
2014 StandoutNobel
Hematological effects of Blastocystis hominis infection in male foreign workers in Taiwan
2003
Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries
2004
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Diagnosis and Treatment of Acute or Persistent Diarrhea
2009
Mucosal immunity and vaccines
2005 Standout
World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010
2015 Standout
The Role of Aeromonas in Diarrhea: a Review
2007
Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore
2007
Pathogenic Escherichia coli
2004 Standout
Progress in enteric vaccine development
2004
Strategies for development of potential candidate Shigella vaccines
1993
PROGNOSIS, COURSE OF DISEASE, AND TREATMENT OF THE SPONDYLOARTHROPATHIES
1998
Platelets and the immune continuum
2011 Standout
Disease burden of selected gastrointestinal pathogens in Australia, 2010
2014
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
High antibiotic susceptibility among bacterial pathogens in Swedish ICUs Report from a nation-wide surveillance program using TA90as a novel index of susceptibility
2004
Foodborne Illness Acquired in the United States—Major Pathogens
2010 Standout
The Common Structural Architecture of Shigella flexneri and Salmonella typhimurium Type Three Secretion Needles
2013 StandoutNobel
No correlation between clinical symptoms and Blastocystis hominis in immunocompetent individuals
2005
Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection
1996
Vaccination Against Enteric Bacterial Diseases
1989
Molecular characterization of the O‐acetyl transferase gene of converting bacteriophage SF6 that adds group antigen 6 to Shigella flexneri
1991
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome
2006
Blastocystis hominis as a cause of hypoalbuminemia and anasarca
2004
Effect of O side‐chain length and composition on the virulence of Shigella flexneri 2a
1996
First Documented Case of Aeromonas veronii Biovar Sobria Infection in Northern Europe
2002
Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia
2004
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Reiter's syndrome and reactive arthritis: A current view
1994
Thrombosis as an intravascular effector of innate immunity
2012 Standout
5′‐Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
2006 StandoutNobel
Overexpression and topology of the Shigella flexneri O‐antigen polymerase (Rfc/Wzy)
1998
The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction.
1999
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Zoonotic Potential and Molecular Epidemiology ofGiardiaSpecies and Giardiasis
2011 Standout
Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine
1996
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Molecular Pathogenesis ofShigellaspp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion
2008
FOCAL ADHESIONS, CONTRACTILITY, AND SIGNALING
1996 Standout
New Insights on Classification, Identification, and Clinical Relevance ofBlastocystisspp
2008 Standout
Chemical Glycobiology
2001 StandoutScienceNobel
Water Microbiology. Bacterial Pathogens and Water
2010 Standout
Leptospirosis
2001 Standout
Pathogenicity Islands of Shigella
2002
Acute Septic Arthritis
2002
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane
1995
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic
2006
BACTERIAL ENTERIC INFECTIONS AND VACCINE DEVELOPMENT
1992
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro
1992
Vaccination against Shigellosis with Attenuated Shigella flexneri 2a Strain SC602
1999
Update on Spondyloarthropathies
2002
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
1999 Standout
Common themes in microbial pathogenicity revisited
1997 Standout
A focal adhesion factor directly linking intracellularly motile Listeria monocytogenes and Listeria ivanovii to the actin-based cytoskeleton of mammalian cells.
1995
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Strategy for Cross-Protection amongShigella flexneriSerotypes
1999
Global Epidemiology of Campylobacter Infection
2015 Standout
Characterization of Functional Oligosaccharide Mimics of the Shigella flexneri Serotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine
2006
Complete Genomic Sequence of SfV, a Serotype-Converting Temperate Bacteriophage of Shigella flexneri
2002
Influence of different rol gene products on the chain length of Shigella dysenteriae type 1 lipopolysaccharide O antigen expressed by Shigella flexneri carrier strains
1997
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
The GenusAeromonas: Taxonomy, Pathogenicity, and Infection
2010 Standout
Genetic requirements for mycobacterial survival during infection
2003 Standout
Enteric Protozoa in the Developed World: a Public Health Perspective
2012
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome
2001
Shigella’s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
2007
Genetic basis of virulence in Shigella species
1991
Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants
1998 Standout
Characterization of the rfc region of Shigella flexneri
1994
Lipopolysaccharide Endotoxins
2002 Standout
Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity
1994
Azithromycin Inhibits the Formation of Flagellar Filaments without Suppressing Flagellin Synthesis in Salmonella enterica Serovar Typhimurium
2005 StandoutNobel
cdc12p, a Protein Required for Cytokinesis in Fission Yeast, Is a Component of the Cell Division Ring and Interacts with Profilin
1997 StandoutNobel
Attenuation of and Protection Induced by a Leucine Auxotroph ofMycobacterium tuberculosis
2000
Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants
1993
Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion
2004 Standout
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
1998 Standout
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant
2007 StandoutNobel
Clinical relevance of Aeromonas sM503
2005
New Gram-negative enteropathogens: fact or fancy?
2006
Works of Anders Kärnell being referenced
Enteropathogens in Adult Patients with Diarrhea and Healthy Control Subjects: A 1-Year Prospective Study in a Swedish Clinic for Infectious Diseases
2000
Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine
1990
Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers
1993
Shigellosis in Vietnam: Seroepidemiologic Studies with Use of Lipopolysaccharide Antigens in Enzyme Immunoassays
1991
AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys
1993
The Lipopolysaccharide of Shigella Bacteria as a Virulence Factor
1991
The pathology of Shigella flexneri infection in Rhesus monkeys: An endoscopic and histopathological study of colonic lesions
1990
An Auxotrophic Live Oral Shigella flexneri Vaccine: Development and Testing
1991
New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units
1999
Development of an auxotrophic oral live Shigella flexneri vaccine
1988
Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes
1992
Immunopathological patterns in the rectal mucosa of patients with shigellosis: expression of HLA‐DR antigens and T‐lymphocyte subsets
1994
Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers
1995
Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study.
1990
Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1
1997
Prevalence of Norovirus among Visitors from the United States to Mexico and Guatemala Who Experience Traveler's Diarrhea
2005
Shigella flexneri infection: a histopathologic study of colonic biopsies in monkeys infected with virulent and attenuated bacterial strains
1991
Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: Characterization and monkey protection studies
1992